Back to News
Market Impact: 0.24
ARPA-H Selects UpDoc to Lead Development of Autonomous Clinical AI System, in an Initiative Joined by Microsoft, OpenAI and NVIDIA
Source: PR Newswire
Artificial IntelligenceHealthcare & BiotechTechnology & InnovationRegulation & Legislation
UpDoc was awarded up to $9.2 million through ARPA-H's ADVOCATE program to develop and validate an autonomous clinical AI system, initially focused on cardiovascular disease. The funding supports future FDA authorization and real-world deployment, representing a positive validation for the company's healthcare AI technology but with limited broad market impact.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately positive
Sentiment Score
0.48
More News
- AI Debt Binge Is Reordering Risk Hierarchy With Emerging Bonds
- CNBC Daily Open: Apple's new iPhone bends. Bond vigilantes, not so much
- Pharvaris at Wells Fargo conference: oral HAE drug gains ground
- Inside India newsletter: India’s green push aims to boost energy security but exposes China dependency
- UBS CEO flags investor complacency as geopolitical and economic risks mount
- Teradyne at Goldman Sachs Communacopia + Technology Conference: ai push widens